| Baseline | 7 months |  |
---|---|---|---|
a, bDemographic and disease characteristics | X | Â | Â |
 aCancer site | X |  |  |
 a, bCancer treatment | X | X |  |
 aTime since diagnosis | X |  |  |
  a6 month prolonged abstinence (primary outcome) |  | X |  |
  Saliva sample or CO breath test (those reporting abstinence) |  | X |  |
 aLength of quit attempts |  | X |  |
 aHeaviness of smoking index (including CPD) | X | X |  |
 aMotivation to Quit | X | X |  |
 aSelf-efficacy to quit | X | X |  |
 aPerceived benefit of quitting | X | X |  |
 aOther smokers in household | X | X |  |
 aPerceived social support | X |  |  |
 aRisk perceptions | X | X |  |
 aUse of pharmacotherapy | X | X |  |
Delivery of cessation support | Â | Â | Â |
 a, bAdvice to quit | X | X |  |
 a, b, cProactive referral to Quitline | X | X |  |
 a, bPrescription or provision of pharmacotherapy (including perceived acceptability) | X | X |  |
Mental health | |||
 aPHQ-4 (+ 2 items from the PHQ to assess panic attack history) | X | X |  |
Substance use | |||
 aAlcohol (AUDIT-C) | X | X |  |
 aCannabis use with tobacco q | X | X |  |
 aCannabis (First question of CUDIT) | X | X |  |
Quality of life | |||
 aFACT–G7 | X | X |  |
Financial effects | |||
 aFinancial stress scale | X | X |  |
 aFinancial distress thermometer | X | X |  |
Patient process measures | |||
 aPatient recall of advice to quit | X | X |  |
 aPatient recall of referral | X | X |  |
 aPatient recall of pharmacotherapy prescription or provision | X | X |  |
 aAttitudes and acceptability of receiving cessation support | X | X |  |
Cost data | |||
 gResource development, training/meetings, equipment/consumables |  | X |  |
 | Baseline | Intervention (12 months duration) | Post-intervention (9–12 months duration depending on step) |
Staff Process measures | |||
 dAdvice to quit | X | X | X |
 dPerceived competence with providing advice to quit | X | X | X |
 dProactive referral to Quitline | X | X | X |
 cNumber of calls and total minutes of completed calls | X | X | X |
 aQuality of contacts with Quitline and reasons for non-use | X | X | X |
 dProportion of smokers with whom staff endorse Quitline | X | X | X |
 cInterstate comparability of Quitline protocols |  | X |  |
 dPrescription or provision of pharmacotherapy | X | X | X |
 dStaff attitudes to pharmacotherapy | X | X | X |
 dStaff acceptability of providing cessation support | X | X | X |
 dTraining in smoking cessation care | X | X | X |
 dExperience and perceptions of Care to Quit intervention |  | X | X |
 ePerceived role of system level factors (staffing, leadership, technology, infrastructure) | X | X | X |
 fAcceptability, experience of delivering smoking cessation counselling to participants |  |  | X |